SC

Sharda Cropchem

Q4 FY25Fertilizers & Agrochemicals

Sharda Cropchem Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹767
Market cap₹6.9K Cr
P/E11.0
Updated26 Aug 2026
Read3 min read

The short version

Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26. FY '26 Revenue Growth: Targeting 10%-15% top-line growth, driven mainly by volume increases and expected pricing improvement.

From Sharda Cropchem's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26.
  • Volume growth expectation is stronger, with 10% to 15% growth forecasted for both agrochemical and non-agrochemical segments.
  • Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them.
  • Regional volume growth in FY '25 was significant: Europe (58%), NAFTA (36%), LatAm (25%).
  • Prices, expected to have pressured margins in FY '25, are forecasted to improve by 10%-15% in FY '26, potentially driving margin expansion.

2 more points from Sharda Cropchem's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Sharda Cropchem said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • For FY '25, Sharda Cropchem's capex was INR 420 crores.
  • The company is confident in ongoing product registrations.
  • Capex guidance for FY '26 is planned to be in the range of INR 400 crores to INR 450 crores.

2 more points from Sharda Cropchem's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sharda Cropchem said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from the Sharda Cropchem Limited Q4 FY '25 earnings call does not explicitly mention details about their current or expected order book or pending orders. However, key insights related to business growth and demand include: - Significant volume growth in Q4 FY '25: over 50% year-on-year overall; agrochemical segment volume growth at 48%. - Strong demand in Europe, Latin America, and NAFTA regions. - The company maintains close customer relationships to align production with demand, especially in Europe.

2 more points from Sharda Cropchem's call on order book

Pro opens every point from 15K+ earnings calls

Sharda Cropchem — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Punjab Chemicals & Crop Protection Ltd (Q4 FY25)

    The company has created inventory strategically to honor its existing order book positions, with about INR25 crores of inventory lying in transit as of March…

  • Gujarat State Fertilizers & Chemicals Ltd (Q4 FY25)

    FY '25 manufacturing volumes were 1.6 million tons, a 15% YoY growth. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's Q4 FY25 earnings…

  • Best Agrolife Ltd (Q4 FY25)

    90 crores, to be spent mostly over 10-12 months starting from around June. Key concall takeaways from Best Agrolife Ltd's Q4 FY25 earnings call — and how it…

  • Insecticides India Ltd (Q4 FY25)

    10-12 crore in FY'26, with potential multiplication in subsequent years (Page 9-12). Key concall takeaways from Insecticides India Ltd's Q4 FY25 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sharda Cropchem and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sharda Cropchem Q4 FY25 results?

Sharda Cropchem is targeting overall top-line growth of 10% to 15% in FY '26. FY '26 Revenue Growth: Targeting 10%-15% top-line growth, driven mainly by volume increases and expected pricing improvement.

What is Sharda Cropchem share price analysis?

Sharda Cropchem currently shows a neutral. The stock trades at a P/E of 11.0 with a market cap of ₹6,865 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sharda Cropchem planning capital expenditure?

For FY '25, Sharda Cropchem's capex was INR 420 crores.

Keep Sharda Cropchem on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.